ANGERLO PHARMA SERVICES LTD
Registered number: 14104752
Balance Sheet
as at 31 May 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 682 154
Current assets
Cash at bank and in hand 6,185 -
Creditors: amounts falling due within one year 4 (5,750) (913)
Net current assets/(liabilities) 435 (913)
Net assets/(liabilities) 1,117 (759)
Capital and reserves
Called up share capital 1 1
Profit and loss account 1,116 (760)
Shareholder's funds 1,117 (759)
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Nana Kofi Twenebua Kodua-Essuman
Director
Approved by the board on 31 October 2024
ANGERLO PHARMA SERVICES LTD
Notes to the Accounts
for the year ended 31 May 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 June 2023 154
Additions 699
At 31 May 2024 853
Depreciation
Charge for the year 171
At 31 May 2024 171
Net book value
At 31 May 2024 682
At 31 May 2023 154
4 Creditors: amounts falling due within one year 2024 2023
£ £
Corporation tax 5,100 913
Other creditors 650 -
5,750 913
5 Other information
ANGERLO PHARMA SERVICES LTD is a private company limited by shares and incorporated in England. Its registered office is:
190 Gillingham Road
Gillingham
ME7 4EY
ANGERLO PHARMA SERVICES LTD 14104752 false 2023-06-01 2024-05-31 2024-05-31 VT Final Accounts April 2022 Nana Kofi Twenebua Kodua-Essuman No description of principal activity 14104752 2022-06-01 2023-05-31 14104752 core:WithinOneYear 2023-05-31 14104752 core:ShareCapital 2023-05-31 14104752 core:RetainedEarningsAccumulatedLosses 2023-05-31 14104752 2023-06-01 2024-05-31 14104752 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 14104752 bus:AuditExemptWithAccountantsReport 2023-06-01 2024-05-31 14104752 bus:Director40 2023-06-01 2024-05-31 14104752 core:PlantMachinery 2023-06-01 2024-05-31 14104752 countries:England 2023-06-01 2024-05-31 14104752 bus:FRS102 2023-06-01 2024-05-31 14104752 bus:FullAccounts 2023-06-01 2024-05-31 14104752 2024-05-31 14104752 core:WithinOneYear 2024-05-31 14104752 core:ShareCapital 2024-05-31 14104752 core:RetainedEarningsAccumulatedLosses 2024-05-31 14104752 core:PlantMachinery 2024-05-31 14104752 2023-05-31 14104752 core:PlantMachinery 2023-05-31 iso4217:GBP xbrli:pure